Member Info for Sagetrade

Not to clog this up anymore, but I agree - tried to say as much over the weekend when billy big *******s mis-construed a single post of mine.

Was happy to play his silly little game privately, he refused claiming no access to said social media platform and instead continued to make public dispersions on me and character.

Has since proceeded to post various links from twitter hence proving beyond doubt that he’s a silly little liar sitting behind his keyboard.

Won’t hear anymore from me now the clowns been outed.

Just calling you out for your blatant lies Poundcake.

As previously stated, bet is on but I won’t hand out personal info on here - send me your twitter handle given you clearly have it, or tweet with hashtags and I’ll find you.

Bizarre really. Giving it extra large all weekend, whilst lying, and now calling me pathetic after it was yourself who kept poking and poking.

“It’s for CIN” mate, come on.

Have a great week ya silly hypocritical c***

Poundcake, I thought you weren't allowed on twitter?

Huh? I didn't think you had twitter big lad?

#rumbled

Fully agree for once Tony - have been saying the “NDA” line is nonsense for months - this government has been leakier than a Persimmon bog so something would have slipped by now / it’s just not viable given what Al himself has said re updating market with TT completion etc.

Not to go all MFM but alastair.smith@avacta.com is genuinely where to direct your frustration. I emailed post interims for clarification on a small point and got a reply the same week.

I’d usually say what a waste of our / his time doing so is given an undoubtedly busy period for him and the company, but frankly it’s becoming a total shambles given the promises and soundbites that were made > 6 weeks ago, and all we’ve had since is the CEO buying a ****ing house (which I have no problem with in isolation)!

Insightful Sujood, insightful.

Go and ask mystic meg ffs......

admirable...I'm sure they'll be a huge demand for that perfect test is 2024.

I have absolutely no doubt about the demand for testing - that isn't a worry for me.

Unfortunately the worry for me, which increases daily, is whether our CEO is commercially astute enough to maximise the opportunity on the table. He seems obsessed with the "perfect" testing solution - all well and good if he delivers and I'll happily eat my words, but we're currently missing out on millions of pounds worth of revenue being swallowed up by inferior tests and hence many multiples of todays share price. Govnt can't throw money at these solutions quick enough, whilst we're still fiddling around behind the scenes. Honestly have no idea what is happening with BAMS......

I agree, everything looks fantastic on paper, in board presentations and every time the CEO speaks.

The problem is, sentiment is wearing thin now. They can present as many fantastically promising slides from the lab as they want, but until shareholders see validation results, sales orders in place, contracts won, or an actual physical product being taken to market then these doubts will remain and increase.

Avacta are a small biotech, not AZ - hence there is legitimate doubts over both the company and CEO about whether they have the acumen and ability to turn what does look like revolutionary science into pound notes. They've been treading water for months now through internal and external delays and issue. I think they have around a week to complete TT and commence validation to have any chance of getting LFT to market for professional use before 2021.

BAMS validation anyone?!

Prototype and lab figures can be as good as they like, simple fact is until Avacta have a product validated and to market the doubts over the CEO’s commercial acumen will remain, and quite rightly too

Because they still haven’t validated BAMS, be it in CONDOR or out, so I have no confidence they can push through validation of the LFF in a short time frame.

They’ve also missed every single deadline set by the CEO thus far.

Becoming an absolute joke that all we’ve had since interims over 6 weeks ago is news of the CEO’s new house purchase.

Totally agree.

Sir Al’s quest for the perfect test has already costs hundreds of millions of pounds in lost revenue and many multiples of current share price.

Let’s hope this is ultimately rewarded, I now have serious doubts we will have the LFT ready for professional use by the end of year.

Fairly tough to disagree with this.

Let's hope Al and the team finally deliver something tangible before the year is out.

Pressure is on and investor patience is beginning to wear thin. Sentiment now gone as shown this week, only significant tangible news flow will suffice from here.

and frankly, RK is the biggest ramper of the lot. Adds v little informed insight and posts largely nonsense......

Yeh, we knew that? It's not ours.

Anyway, I've topped up this morning for my sins. Come on Al ffs.

Just beware of that damned official secrets act though eh Tony lad?

Point me to where I said I was selling?

Merely pointing out the absolute tripe that some spew on here that never gets shot down.

This moron is still claiming TT “might” be complete. It’s beyond parody.

They will miss the boat if the prototype design cannot be turned into an effectively manufactured mass testing tool. I will fully agree that once pilot batch is produced, validation and MASS sales are an inevitability, but anyone who doeusn’t accept this is the last MAJOR risk hurdle for the LFT is either naive or disingenuous...

Totally agree re diagnostics being a bonus to therapeutic side, but whether you like it or not the simple fact of the matter is that current and medium term share price is going to be solely based on the former.

Was in way before £2 and I’m no covid chaser. Still hold full holding here and haven’t traded once. It’s legitimate to pose questions and shut down nonsense ramping without being told to “shut up or sell up” - especially on a discussion board....

“Feels very close”

We haven’t even finished the tooling process pal.

Regardless of your thoughts on how long covid testing will be needed, time IS a limiting factor, and Avacta are in danger of missing the boat here.

BAMS validation delay is now becoming laughable I’m afraid.

Why have no additional manufacturing partners been agreed for LFT? Why has no manufacturing partner for BAMS been announced? No news on these licensing agreements Al mentioned either.

The Q4 clock continues to tick. Investors won’t accept further missed deadlines here.